Nonenzymatic glycosylation: A biochemical link between chronic hyperglycemia and pathophysiologic processes associated with diabetic complications and aging related debilities

Biomedicine and Aging Pathology

Volumn 2, Issue 4, 2012, Pages 133-142

  Nimbalkar, Vikram V ^a   Mandlik, Rahul V ^b,c   Naik, Suresh R ^d   Maseeh, Arun ^b  

^a PDVVPF's College of Pharmacy Vilad Ghat   (India)

^b Torrent Pharmaceuticals Ltd   (India)

^c Pacific Academy of Higher Education and Research   (India)

^d Sinhgad Institute of Pharmaceutical Sciences   (India)

Author keywords

Advanced glycation end products; Aging; Diabetic complications; Receptors for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; APOLIPOPROTEIN B; CASPASE 8; CASPASE 9; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; ELASTIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELIN; PROTEOGLYCAN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

AGING; ALZHEIMER DISEASE; APOPTOSIS; ATHEROSCLEROTIC PLAQUE; BINDING SITE; BIOLOGICAL ACTIVITY; CARTILAGE; CHEMICAL MODIFICATION; CHEMICAL REACTION; COMPLEX FORMATION; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCEMIC CONTROL; GLYCOSYLATION; HALF LIFE TIME; HUMAN; HYPERGLYCEMIA; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; NEUROFILAMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; UPREGULATION; VASCULAR AMYLOIDOSIS;

EID: 84871361321     PISSN: 22105220     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomag.2012.08.001     Document Type: Review

References (97)

1. Nessar, and Ahmed Advanced glycation endproducts - role in pathology of diabetic complications Diabetes Res Clin Prac 67 2005 3 21
2. M. Brownlee, H. Vlassara, and A. Cerami Nonenzymatic glycosylation and the pathogenesis of diabetic complications Ann Intern Med 101 1984 527 537
3. S.L. Schnider, and R.R. Kohn Glucosylation of human collagen in aging and diabetes mellitus J Clin Invest 66 1980 1179 1181
4. R. Fluckiger, and K.H. Winterhalter In vitro synthesis of hemoglobin A1c FEBS Lett 71 1976 356 360
5. C.R. Hamlin, and R.R. Kohn Evidence for progressive, age-related structural changes in post-mature human collagen Biochim Biophys Acta 236 1971 458 467
6. D. Harman Free radical theory of aging. Increasing the functional life span Ann N Y Acad Sci 717 1994 1 15
7. V.M. Monnier, and A. Cerami Nonenzymatic browning in vivo: possible process for aging of long-lived proteins Science 211 1981 491 493
8. D.S. Raj, D. Choudhury, T.C. Welbourne, and M. Levi Advanced glycation endproducts: A nephrologist's perspective Am J Kidney Dis 35 2000 365 380
9. V.M. Monnier, R.R. Kohn, and A. Cerami Accelerated age-related browning of human collagen in diabetes mellitus Proc Natl Acad Sci U S A 81 1984 583 587
10. B.P. Shagan Is diabetes a model for aging? Med Clin North Am 60 1976 1209 1211
11. J.W. Baynes The role of AGEs in aging: causation or correlation Exp Gerontol 36 2001 1527 1537
12. H.R. Bruce, Wolffenbuttel, and T.W.R. Haeften Prevention of complications in NIDDM Drugs 50 1995 263 288
13. A.T. Lee, and A. Cerami Role of glycation in aging Ann N Y Acad Sci 663 1992 63 70
14. H.F. Bunn, and P.J. Higgins Reaction of monosaccharides with proteins: possible evolutionary significance Science 213 1981 222 224
15. S.J. Zieman, and A.K. David Advanced glycation endproducts crosslinking in the cardiovascular system. Potential therapeutic target for cardiovascular disease Drugs 64 2004 459 470
16. A.S. Elbe, S.R. Thorpe, and J.W. Baynes Nonenzymatic glucose and glucose-dependent crosslinking of protein J Biol Chem 258 1983 9406 9412
17. M. Brownlee, A. Cerami, and H. Vlassara Advanced glycosylation endproducts in tissue and the biochemical basis of diabetic complications NEJM 318 1988 1315 1321
18. S.P. Wolff, and R.T. Dean Glucose autoxidation and protein modification. The potential role of "autoxidative glycosylation" in diabetes Biochem J 245 1987 243 250
19. P.J. Thornalley, A. Langborg, and H.S. Minhas Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose Biochem J 344 1999 109 116
20. M. Kasper, and R.H.W. Funk Age-related changes in cells and tissues due to advanced glycation end products (AGEs) Arch Geront Geriat 32 2001 233 243
21. M. Brownlee, H. Vlassara, and A. Cerami Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein Diabetes 34 1985 938 941
22. V.M. Monnier, B.A.V. Vishwanath, K.E. Frank, C.A. Elmets, P. Dauchot, and R.R. Kohn Relation between complications of type I diabetes mellitus and collagen-linked fluorescence NEJM 314 1986 403 408
23. R.G. Paul, and A.J. Bailey The effect of advanced glycation endproduct formation upon cell matrix interactions Int J Biochem Cell Biol 31 1999 653 660
24. M. Brownlee, S. Pongor, and A. Cerami Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. Role in the in situ formation of immune complexes J Exp Med 158 1983 1739 1744
25. I. Giardino, D. Edelstein, and M. Brownlee Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity: A model for intracellular glycosylation in diabetes J Clin Invest 94 1994 110 117
26. B.S. Szwergold, F. Kappler, and T.R. Brown Identification of fructose-3-phosphate in the lens of diabetic rats Science 247 1990 451 454
27. H. Vlassara, and M.R. Palace Diabetes and advanced glycation endproducts J Intern Med 251 2002 87 101
28. J.W. Baynes Role of oxidative stress in development of complications in diabetes Diabetes 40 1991 405 412
29. R. Bucala, K.J. Tracey, and A. Cerami Advanced glycosylation end products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes J Clin Invest 87 1991 432 438
30. Y. Kaji, S. Amano, T. Usui, T. Osbika, K. Yamahiro, and S. Isbida Expression and function of receptors for AGEs in bovine corneal endothelial cells Invest Opthal Visual Sci 44 2003 521 528
31. S.L. Schnider, and R.R. Kohn Effect of age and diabetes mellitus on the solubility and nonenzymatic glucosylation of human skin collagen J Clin Invest 67 1981 1630 1635
32. D.M. Stern, S.D. Yan, S.F. Yan, and A.M. Schmidt Receptors for advanced glycation endproducts (RAGE) and the complications of diabetes Age Res Rev 1 2002 1 15
33. J.L. Wautier, and P.J. Guillausseau Advanced glycation end products, their receptors and diabetic angiopathy Diabetes Metab 27 2001 535 542
34. Z. Alikhani, M. Alikhani, C.M. Boyd, K. Nagao, P.C. Trackman, and D.T. Graves Advanced glycation end products enhance expression of pro-Apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways J Biol Chem 280 2005 12087 12095
35. A.M. Schmidt, R. Mora, and R. Cao The endothelial cell-binding site for advanced glycation endproducts consists of a complex: An integral membrane protein and a lactoferrin- like polypeptide J Biol Chem 269 1994 9882 9888
36. B.I. Hudson, L.G. Bucciarelli, T. Wendt, T. Sakaguchi, E. Lalla, and W. Qu Blockade of receptors for advanced glycation endproducts:a new target for therapeutic intervention in diabetic complications and inflammatory disorders Arch Biochem Biophys 419 2003 80 88
37. S.D. Yan, A.M. Schmidt, and G.M. Anderson Enhanced cellular oxidative stress by the interaction of advanced glycation endproducts with their receptors/binding proteins J Biol Chem 269 1994 9889 9897
38. H. Vlassara, M. Brownlee, and K.R. Monogue Cachectin/TNF and IL-1 induced by glucose modified proteins: role in normal tissue remodeling Science 240 1988 1546 1548
39. R. Ramasamy, S.J. Vannucci, S.S.D. Yan, K. Herold, S.F. Yan, and A.N. Schmidt Advanced glycation end products and RAGE: A common thread in aging, diabetes, neurodegeneration, and inflammation Glycobiology 15 2005 16R 28R
40. S.F. Yan, and D'Agati V et al Receptor for Advanced Glycation Endproducts (RAGE): A formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging Curr Mol Med 7 8 2007 699 710
41. X. Song, M. Bao, D. Li, and Y.M. Li Advanced glycation in D-galactose induced mouse aging model Mech Ageing Dev 108 1999 239 251
42. A.I. Vinik, M.T. Holland, and J.M. LeBeau Diabetic neuropathies Diabetes Care 15 1992 1927 1935
43. J.W. Baynes The Maillard hypothesis on aging: time to focus on DNA Ann N Y Acad Sci 959 2002 360 367
44. R. Bucala, P. Model, and A. Cerami Modification of DNA by reducing sugars: A possible mechanism for nucleic acid aging and age related dysfunction in gene expression Proc Natl Acad Sci U S A 81 1984 105 109
45. R. Bucala, P. Model, M. Russel, and A. Cerami Modification of DNA by glucose-6-phosphate induces DNA rearrangements in an Escherichia coli plasmid Proc Natl Acad Sci U S A 82 1985 8439 8442
46. G.B. Price, S.P. Modak, and T. Makinodan Age-Associated changes in the DNA of mouse tissue Science 171 1971 917 920
47. J.A. Dunn, J.S. Patrick, S.R. Thorpe, and J.W. Baynes Oxidation of glycated proteins: Age-dependent accumulation of N-(carboxymethyl)lysine in lens proteins Biochemistry 28 1989 9464 9468
48. R.G. Culter Free radicals in biology 6 1984 Academic Press New York p. 371-428
49. J.V. Hunt, C.C.T. Smith, and S.P. Wolff Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose Diabetes 39 1990 1420 1424
50. S.R. Naik Antioxidants and their role in biological functions: An overview Indian Drugs 40 2003 501 516
51. P.B. Duell, J.F. Oram, and E.L. Bierman Nonenzymatic glycosylation of HDL and impaired HDL-receptor-mediated cholesterol efflux Diabetes 40 1991 405 411
52. C. Lee, M.B. Yim, P.B. Chock, H.S. Yim, and S.O. Kang Oxidation-reduction properties of methylglyoxal-modified protein in relation to free radical generation J Biol Chem 273 1998 25272 25278
53. C.J. Mullarkey, D. Edelstein, and M. Brownlee Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes Biochem Biophys Res Commun 173 1990 932 939
54. M. Qian, M. Liu, and J.W. Eaton Transiton metals bind to glycated proteins forming redox active glycochelates: implication for the pathogenesis of certain diabetic complications Biochem Biophys Res Commun 250 1998 385 389
55. A.K. Saxena, P. Saxena, X. Wu, M. Obrenovich, M.F. Weiss, and V.M. Monnier Protein aging by carboxymethylation of lysines generates sites for divalent metal and redox active copper binding: relevance to diseases of glycoxidative stress Biochem Biophys Res Commun 260 1999 332 338
56. A.F. Jones, and J. Lunec Protein fluorescence and its relationship to free radical activity Br J Cancer (Suppl. VIII) 56 1987 60 65
57. A.D. Bats, and E.L. Rhodes Innate fluorescence in diabetic and aged kidneys Lancet 26 1974 137 138
58. H.C. Pillsbury, W. Hung, M.C. Kyle, and E.D. Freis Arterial pulse waves and velocity and systolic time intervals in diabetic children Am Heart J 87 1974 783 790
59. J.A. Miller, E. Gravalles, and H.F. Bunn Nonenzymatic glycosylation of erythrocyte membrane protein. Relevance to diabetes J Clin Invest 65 1980 896
60. M.R. Schuyler, D.E. Niewoehner, S.C. Inkley, and R. Kohn Abnormal lung elasticity in juvenile diabetes mellitus Am Rev Resp Dis 113 1976 37 41
61. C.R. Hamlin, R.R. Kohn, J.H. Luschin, and B.A. Cleveland Apparent accelerated aging of human collagen in diabetes mellitus Diabetes 24 1975 902 904
62. V.J. Stevens, C.A. Rouzer, V.M. Monnier, and A. Cerami Diabetic cataract formation: potential role of glycosylation of lens crystallins Proc Natl Acad Sci U S A 75 1978 2918 2922
63. A.J. Bailey Molecular mechanism of aging in connective tissues Mech Ageing Dev 122 2001 735 755
64. M. Brownlee, H. Vlassara, A. Kooney, P. Ulrich, and A. Cerami Aminoguanidine prevents diabetes induced arterial wall protein cross-linking Science 232 1986 1629 1632
65. M.J.C. Kent, N.D. Light, and A.J. Bailey Evidence for glucose mediated covalent cross-linking of collagen after glycosylation in vitro Biochem J 225 1985 745 752
66. J. Uitto, K. Ohlenschlager, and I.B. Lorenzen Solubility of skin collagen in normal human subjects and in patients with generalized scleroderma Clin Chim Acta 31 1971 13 18
67. C.P. Winlove, K.H. Parker, and N.C. Avery Interactions of elastin and aorta with sugars in vitro and their effects on biochemical and physical properties Diabetologia 39 1996 1131 1139
68. J.F. Day, R.W. Thornburg, S.R. Thorpe, and J.W. Baynes Nonenzymatic glycosylation of rat albumin: Studies in vitro and in vivo J Biol Chem 254 1979 9394 9400
69. R. Bucala, R. Mitchell, and K. Arnold Identification of major site of apolipoproteinB modification by advanced glycosylation end products blocking uptake by the low-density lipoprotein receptor J Biol Chem 270 1995 10828 10832
70. J.L. Witztum, and D. Steinberg Role of oxidized low-density lipoprotein in atherogenesis J Clin Invest 88 1991 1785 1792
71. E.D. Schleicher, E. Wagner, and A.G. Nerlich Increased accumulation of the glyoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging J Clin Invest 99 1997 457 468
72. G. Munch, S. Mayer, J. Michaelis, A.R. Hipkiss, P. Riederer, and R. Muller Influence of advanced glycation endproducts and AGE-inhibitors on nucleation-dependent polymerization of beta-Amyloid peptide Biochem Biophys Acta 1360 1997 17 29
73. K.J. Bar, S. Franke, B. Wenda, S. Muller, R. Kientsch-Engel, and G. Stein Pentosidine and N- (carboxymethyl)-lysine in Alzheimer's disease and vascular dementia Neurobiol Aging 24 2003 333 338
74. N. Sasaki, R. Fukatsu, K. Tsuzuki, Y. Hayashi, T. Yoshida, and N. Fujii Advanced glycation end products in Alzheimer's disease and other neurodegenarative diseases Am J Pathol 153 1998 1149 1155
75. R. Dei, A. Takeda, H. Niwa, M. Li, Y. Nakagomi, and M. Watanabe Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease Acta Neuropathologica 104 2002 113 122
76. J.L. Witztum, U.P. Steinbrecher, M. Fisher, and A. Kesaniemi Nonenzymatic glycosylation of homologous low density lipoprotein and albumin renders them immunogenic in guinea pig Proc Natl Acad Sci U S A 80 1983 2757 2761
77. W.G. Couser, and D.J. Salant In situ immune complex formation and glomerular injury Kidney Int 17 1980 1
78. T. Cavallo, J.A. Pinto, L.C. Abbott, and S. Rajaraman Immune complex disease complicating diabetic glomerulosclerosis Lab Invest 48 1983 13A
79. Z. Turk, S. Ljubic, N. Turk, and B. Benko Detection of autoantibodies against advanced glycation end products and AGE-immune complexes in serum of patients with diabetes mellitus Clin Chim Acta 303 2001 105 115
80. D.K. Miller Activation of apoptosis and its inhibition Ann N Y Acad Sci 886 1999 132 157
81. M.E. Obrenovich, and V.M. Monnier Apoptotic killing of fibroblasts by matrix-bound advanced glycation endproducts Sci Aging Knowl Environ 2005 4 2005 pe3
82. H. Konishi, M. Nakatsuka, C. Chekir, S. Noguchi, Y. Kamada, and A. Sasaki Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblast Hum Reprod 19 2005 2156 2162
83. D. Huang, J. Wang, P. Kivisakk, B. Rollins, and R. Ransohoff Absence of monocyte chemoattractant protein I in mice leads to decreased local macrophage recruitment and antigen specific T-helper cells type I immune response in experimental autoimmune encephalomyelitis J Exp Med 193 2001 713 726
84. R.A. Kowluru Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions Life Sci 76 2005 1051 1060
85. S. Yamagishi, Y. Inagaki, T. Okamoto, S. Amano, K. Koga, and M. Takeuchi Advanced glycation product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human cultured mesangial cells J Biol Chem 277 2002 20309 20315
86. M.L. Agarwal, W.R. Taylor, M.V. Chernov, O.B. Chernov, and G.R. Stark The p53 network J Biol Chem 273 1998 1 4
87. R. Schiel Improvement of the quality of diabetes control and disease in the concentration of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus studied over a period of 10 years (JEVIN) J Diabet Complications 17 2003 90 97
88. F. Igaki Hata, N. Nakamichi, T. Masuda, S. Nishimoto, and S.M. Oimomi Suppresive effect of α-ketogluteraldehyde dehydrogenase on the advanced process of the Maillard reaction Diabetes Res Clin Practice 5 1988 5413
89. H. Vlassara, M. Brownlee, and A. Cerami Specific macrophage receptor activity for advanced glycosylation endproducts inversely correlates with insulin levels in vivo Diabetes 37 1988 456 461
90. H. Yamamoto, T. Watanabe, and Y. Yamamoto RAGE in diabetic nephropathy Curr Mol Med 7 8 2007 752 757
91. M. Negrean, and A. Stirban Effects of low- and high-Advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus Am J Clin Nutr 85 5 2007 1236 1243
92. M.S. Wu, and J.T. Liang Aminoguanidine prevents the impairment of cardiac pumping mechanics in rats with streptozotocin and nicotinamide-induced type 2 diabetes Br J Pharmacol 154 4 2008 758 764
93. M.E. Cooper, V. Thallas, J. Forbes, E. Scalbert, S. Sastra, and I. Darby The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation Diabetologia 43 2000 660 664
94. M.E. Williams Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease Curr Diab Rep 4 2004 441 446
95. S. Vasan, X. Zhang, and X. Zhang An agent cleaving glucose-derived protein crosslinks in vitro and in vivo Nature 382 1996 275 278
96. A.W. Stitt Advanced glycation: An important pathological event in diabetic and age related ocular disease Br J Ophthalmol 85 2001 746 753
97. D. Dayal Understanding diabetes from a new perspective: the role of free radicals Free Radic Biol Med 77 222 2005 1 20